NCT02899338View on ClinicalTrials.gov

Pharmacokinetics and Safety of BI 695501

PHASE1CompletedINTERVENTIONAL
Enrollment

162

Participants

Timeline

Start Date

September 21, 2016

Primary Completion Date

February 9, 2017

Study Completion Date

February 23, 2017

Conditions
Healthy
Interventions
DRUG

BI695501 Prefilled syringe

DRUG

BI695501Autoinjector

Trial Locations (2)

2060

SGS Life Sciences Services, Antwerp

9728 NZ

PRA Health Sciences Onderzoekscentrum Martini, Groningen

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY